FOXD4L4
gene geneOn this page
Also known as bA460E7.2OTTHUMG00000013337OTTHUMG00000066752
Summary
FOXD4L4 (forkhead box D4 like 4, HGNC:23762) is a protein-coding gene on chromosome 9q21.11, encoding Forkhead box protein D4-like 4 (Q8WXT5).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in anatomical structure morphogenesis; cell differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.
Source: NCBI Gene 349334 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_199244
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23762 |
| Approved symbol | FOXD4L4 |
| Name | forkhead box D4 like 4 |
| Location | 9q21.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA460E7.2, OTTHUMG00000013337, OTTHUMG00000066752 |
| Ensembl gene | ENSG00000184659 |
| Ensembl biotype | protein_coding |
| OMIM | 611085 |
| Entrez | 349334 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377413
RefSeq mRNA: 1 — MANE Select: NM_199244
NM_199244
CCDS: CCDS75845
Canonical transcript exons
ENST00000377413 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001771836 | 65737146 | 65738396 |
Expression profiles
Bgee: expression breadth broad, 46 present calls, max score 54.22.
Top tissues by expression
89 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 54.22 | gold quality |
| stromal cell of endometrium | CL:0002255 | 53.53 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 51.04 | gold quality |
| cortical plate | UBERON:0005343 | 48.24 | silver quality |
| cerebellum | UBERON:0002037 | 47.00 | silver quality |
| cerebellar cortex | UBERON:0002129 | 46.92 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 46.80 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 45.75 | silver quality |
| Ammon’s horn | UBERON:0001954 | 45.61 | gold quality |
| prefrontal cortex | UBERON:0000451 | 45.44 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 45.33 | gold quality |
| frontal cortex | UBERON:0001870 | 45.16 | gold quality |
| primary visual cortex | UBERON:0002436 | 44.71 | silver quality |
| cerebral cortex | UBERON:0000956 | 44.59 | gold quality |
| bone marrow cell | CL:0002092 | 44.43 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 44.42 | gold quality |
| nucleus accumbens | UBERON:0001882 | 44.38 | gold quality |
| ventricular zone | UBERON:0003053 | 44.29 | silver quality |
| right frontal lobe | UBERON:0002810 | 43.99 | gold quality |
| granulocyte | CL:0000094 | 43.82 | silver quality |
| ganglionic eminence | UBERON:0004023 | 43.57 | gold quality |
| brain | UBERON:0000955 | 42.43 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 42.03 | gold quality |
| tonsil | UBERON:0002372 | 42.01 | gold quality |
| tibial nerve | UBERON:0001323 | 41.61 | gold quality |
| caudate nucleus | UBERON:0001873 | 41.52 | gold quality |
| putamen | UBERON:0001874 | 41.41 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 40.85 | silver quality |
| hypothalamus | UBERON:0001898 | 40.60 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 39.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Foxd4 | ENSMUSG00000051490 |
Paralogs (41): FOXP3 (ENSG00000049768), FOXC1 (ENSG00000054598), FOXJ2 (ENSG00000065970), FOXF1 (ENSG00000103241), FOXN1 (ENSG00000109101), FOXM1 (ENSG00000111206), FOXP1 (ENSG00000114861), FOXO3 (ENSG00000118689), FOXA2 (ENSG00000125798), FOXA1 (ENSG00000129514), FOXJ1 (ENSG00000129654), FOXK2 (ENSG00000141568), FOXO1 (ENSG00000150907), FOXH1 (ENSG00000160973), FOXQ1 (ENSG00000164379), FOXK1 (ENSG00000164916), FOXD4 (ENSG00000170122), FOXA3 (ENSG00000170608), FOXB1 (ENSG00000171956), FOXR1 (ENSG00000176302), FOXL1 (ENSG00000176678), FOXC2 (ENSG00000176692), FOXE1 (ENSG00000178919), FOXS1 (ENSG00000179772), FOXL2 (ENSG00000183770), FOXO4 (ENSG00000184481), FOXD4L1 (ENSG00000184492), FOXD2 (ENSG00000186564), FOXI2 (ENSG00000186766), FOXE3 (ENSG00000186790), FOXD3 (ENSG00000187140), FOXD4L3 (ENSG00000187559), FOXR2 (ENSG00000189299), FOXJ3 (ENSG00000198815), FOXO6 (ENSG00000204060), FOXB2 (ENSG00000204612), FOXD4L5 (ENSG00000204779), FOXI3 (ENSG00000214336), FOXL3 (ENSG00000248767), FOXD1 (ENSG00000251493)
Protein
Protein identifiers
Forkhead box protein D4-like 4 — Q8WXT5 (reviewed: Q8WXT5)
Alternative names: Forkhead box protein D4-like 2, Forkhead box protein D4B, Myeloid factor-gamma
All UniProt accessions (1): Q8WXT5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (1): NP_954714* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001766 | Fork_head_dom | Domain |
| IPR018122 | TF_fork_head_CS_1 | Conserved_site |
| IPR030456 | TF_fork_head_CS_2 | Conserved_site |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR050211 | FOX_domain-containing | Family |
Pfam: PF00250
UniProt features (7 total): region of interest 2, compositionally biased region 2, chain 1, DNA-binding region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WXT5-F1 | 57.50 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 15 (showing top):
BENPORATH_ES_WITH_H3K27ME3, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, chr9q21, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP, HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOCC_CHROMATIN, ACEVEDO_LIVER_CANCER_DN, BENPORATH_EED_TARGETS, BENPORATH_PRC2_TARGETS, BENPORATH_SUZ12_TARGETS
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), anatomical structure morphogenesis (GO:0009653), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| developmental process | 1 |
| anatomical structure development | 1 |
| cellular developmental process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
400 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOXD4L4 | OR13C3 | Q8NGS6 | 542 |
| FOXD4L4 | OR13C4 | Q8NGS5 | 524 |
| FOXD4L4 | MAP10 | Q9P2G4 | 417 |
| FOXD4L4 | DUSP19 | Q8WTR2 | 359 |
| FOXD4L4 | HIC2 | Q96JB3 | 359 |
| FOXD4L4 | RPL3L | Q92901 | 345 |
| FOXD4L4 | PRB4 | P02813 | 325 |
| FOXD4L4 | PCDHB9 | Q9Y5E1 | 324 |
| FOXD4L4 | GTF2A1 | P52655 | 316 |
| FOXD4L4 | FOXR2 | Q6PJQ5 | 290 |
| FOXD4L4 | DMRT3 | Q9NQL9 | 281 |
| FOXD4L4 | DMRT2 | Q9Y5R5 | 279 |
| FOXD4L4 | KIAA1958 | Q8N8K9 | 276 |
| FOXD4L4 | DMRT1 | Q9Y5R6 | 276 |
| FOXD4L4 | SERF1A | O75920 | 270 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOXD4L4 | MAPRE3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAPRE3 | FOXD4L4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): FOXD4L4 (Two-hybrid)
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0JNN8, A6NF83, A6NHQ4, A6QPM6, A8E4L3, A8MTW9, B2KGE5, C9JVW0, I3L1E1, O43541, O75474, O75638, P0C7X2, P70339, P89439, Q02080, Q05215, Q12950, Q3SYB3, Q5T230, Q5VV16, Q6NZ36, Q6NZY7, Q6P1X6, Q6VB84, Q6VUC0, Q6VUP9, Q6ZSJ8, Q7RTU5, Q7TNS8, Q80WY3, Q86SI9, Q86UU5, Q8K025
Diamond homologs: A0A078BQN7, A0A1W2PRP0, A0A8V0YY16, A1L1S5, A3KNJ3, A8MTJ6, A8XJN7, B5RHS5, D3Z120, F1R8Z9, O00358, O17617, O43638, O54743, O60129, O88470, P32027, P32028, P32030, P32315, P42128, P55316, P56260, P58012, P79772, P85037, P91278, Q00939, Q01167, Q02360, Q12946, Q12947, Q12948, Q12950, Q12951, Q12952, Q13461, Q19802, Q1A1A1, Q1A1A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2674 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:65737641:T:C | F166L | 1.000 |
| 9:65737642:T:C | F166S | 1.000 |
| 9:65737642:T:G | F166C | 1.000 |
| 9:65737643:C:A | F166L | 1.000 |
| 9:65737643:C:G | F166L | 1.000 |
| 9:65737691:G:C | W182C | 1.000 |
| 9:65737691:G:T | W182C | 1.000 |
| 9:65737554:T:C | F137L | 0.999 |
| 9:65737556:C:A | F137L | 0.999 |
| 9:65737556:C:G | F137L | 0.999 |
| 9:65737569:T:C | F142L | 0.999 |
| 9:65737571:C:A | F142L | 0.999 |
| 9:65737571:C:G | F142L | 0.999 |
| 9:65737599:T:A | W152R | 0.999 |
| 9:65737599:T:C | W152R | 0.999 |
| 9:65737601:G:C | W152C | 0.999 |
| 9:65737601:G:T | W152C | 0.999 |
| 9:65737612:T:A | I156N | 0.999 |
| 9:65737617:C:G | H158D | 0.999 |
| 9:65737619:C:A | H158Q | 0.999 |
| 9:65737619:C:G | H158Q | 0.999 |
| 9:65737622:C:A | N159K | 0.999 |
| 9:65737622:C:G | N159K | 0.999 |
| 9:65737624:T:A | L160H | 0.999 |
| 9:65737624:T:C | L160P | 0.999 |
| 9:65737633:A:T | N163I | 0.999 |
| 9:65737689:T:A | W182R | 0.999 |
| 9:65737689:T:C | W182R | 0.999 |
| 9:65737719:T:C | F192L | 0.999 |
| 9:65737720:T:G | F192C | 0.999 |
dbSNP variants (sampled 300 via entrez): RS10796795 (9:65737984 G>C), RS11263204 (9:65736157 C>A,G), RS11263205 (9:65735889 T>G), RS11263206 (9:65735843 C>G), RS11263207 (9:65735804 C>A,T), RS11263208 (9:65735516 C>G,T), RS1156649699 (9:65735545 G>A), RS1157164734 (9:65738435 C>T), RS1157695951 (9:65735809 CAAAAAAA>C,CA,CAA,CAAA,CAAAA,CAAAAA,CAAAAAA,CAAAAAAAA,CAAAAAAAAA,CAAAAAAAAAA,CAAAAAAAAAAA), RS1157793211 (9:65737807 T>C), RS1158322043 (9:65737316 G>A,C,T), RS1158783841 (9:65736863 T>C), RS1158840262 (9:65736224 A>C,G), RS1158991008 (9:65738424 G>A), RS1159207892 (9:65737275 G>A,C)
Disease associations
OMIM: gene MIM:611085 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Smoke | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A1Y8 | SEES3-1V human FOXD4L4, clone1 | Embryonic stem cell | Male |
| CVCL_A1Y9 | SEES3-1V human FOXD4L4, clone2 | Embryonic stem cell | Male |
| CVCL_A1Z0 | SEES3-1V human FOXD4L4, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.